The Board of Directors of Moberg Pharma has resolved on record date for the reverse share split
The Annual General Meeting in Moberg Pharma AB (publ) (“Moberg Pharma” or the “Company”) on 16 May 2023 resolved on a reverse share split, through which ten existing shares will be consolidated into one share (Sw: Sammanläggning 1:10). The Board of Directors was authorized by the Annual General Meeting to resolve on the record date for the reverse share split. The Board of Directors now resolved that the record date for the reverse share split will be 25 May 2023.The Board of Directors' resolution means that the last day of trading in Moberg Pharma's share prior to the reverse share split